Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma
- 1 February 2005
- journal article
- case report
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 71 (3), 315-318
- https://doi.org/10.1007/s11060-004-2028-0
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Thalidomide for the treatment of patients with myelodysplastic syndromesLeukemia, 2002
- Temozolomide for recurrent high-grade gliomaSeminars in Oncology, 2001
- A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapseBritish Journal of Cancer, 2000
- Risk of Leukemia after Chemotherapy and Radiation Treatment for Breast CancerNew England Journal of Medicine, 1992
- Late toxicities and complications in three-year survivors of small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Leukaemia complicating treatment for Hodgkin's disease: the experience of the British National Lymphoma Investigation.BMJ, 1990
- Leukemia after Adjuvant Chemotherapy with Semustine (Methyl-CCNU) — Evidence of a Dose–Response EffectNew England Journal of Medicine, 1986
- Acute nonlymphocytic leukemia following treatment of malignant gliomaJournal of Neurosurgery, 1984
- Two cases of acute leukemia following treatment of malignant gliomaCancer, 1983
- Clinical Toxicity of Combined Modality Treatment with Nitrosourea Derivatives for Central Nervous System TumorsNeurosurgery, 1982